Key Insights

Highlights

Success Rate

57% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

42.9%

3 terminated out of 7 trials

Success Rate

57.1%

-29.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

57% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed4
Terminated3

Trial Success Rate

57.1%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (7)

Research Network

Activity Timeline